Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hellmann

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
AIDS Research and Human Retroviruses|January 25, 2005
Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordanceSusan S Kaplan, Guido Ferrari, Terri Wrin, et al.
The Journal of Infectious Diseases|February 25, 2003
Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated populationAndrew J Leigh Brown, Simon D W Frost, W Christopher Mathews, et al.
Nature Communications|September 20, 2012
Time-domain classification of charge-density-wave insulatorsS Hellmann, T Rohwer, M Kalläne, et al.
JAMA|January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimensD V Havlir, N S Hellmann, C J Petropoulos, et al.
JAMA|July 4, 2002
Time trends in primary HIV-1 drug resistance among recently infected personsRobert M Grant, Frederick M Hecht, Maria Warmerdam, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patientsNancy S Shulman, Michael D Hughes, Mark A Winters, et al.
Antiviral Therapy|February 6, 2004
Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistanceJoel E Gallant, Peter Z Gerondelis, Mark A Wainberg, et al.
The Journal of Infectious Diseases|January 3, 2001
Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infectionS A Call, M S Saag, A O Westfall, et al.
The Journal of Infectious Diseases|December 12, 2001
Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposureM E Roland, J N Martin, R M Grant, et al.
The New England Journal of Medicine|February 15, 2001
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremiaS G Deeks, T Wrin, T Liegler, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
AIDS Research and Human Retroviruses|January 25, 2005
Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordanceSusan S Kaplan, Guido Ferrari, Terri Wrin, et al.
The Journal of Infectious Diseases|February 25, 2003
Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated populationAndrew J Leigh Brown, Simon D W Frost, W Christopher Mathews, et al.
Nature Communications|September 20, 2012
Time-domain classification of charge-density-wave insulatorsS Hellmann, T Rohwer, M Kalläne, et al.
JAMA|January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimensD V Havlir, N S Hellmann, C J Petropoulos, et al.
JAMA|July 4, 2002
Time trends in primary HIV-1 drug resistance among recently infected personsRobert M Grant, Frederick M Hecht, Maria Warmerdam, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patientsNancy S Shulman, Michael D Hughes, Mark A Winters, et al.
Antiviral Therapy|February 6, 2004
Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistanceJoel E Gallant, Peter Z Gerondelis, Mark A Wainberg, et al.
The Journal of Infectious Diseases|January 3, 2001
Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infectionS A Call, M S Saag, A O Westfall, et al.
The Journal of Infectious Diseases|December 12, 2001
Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposureM E Roland, J N Martin, R M Grant, et al.
The New England Journal of Medicine|February 15, 2001
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremiaS G Deeks, T Wrin, T Liegler, et al.
Pageof 6